MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fendo.2023.1155007

Медицинская библиотека · Frontiers in endocrinology · 2023

Does fasting plasma glucose values 5.1-5.6 mmol/l in the first trimester of gestation a matter?

Ramezani Tehrani Fahimeh, Farzadfar Farshad, Hosseinpanah Farhad, Rahmati Maryam, Firouzi Faegheh, Abedini Mehrandokht, Hadaegh Farzad, Valizadeh Majid, Torkestani Farahnaz, Khalili Davood, Solaymani-Dodaran Masoud, Bidhendi-Yarandi Razieh, Bakhshandeh Marzieh, Ostovar Afshin, Dovom Marzieh Rostami, Amiri Mina, Azizi Fereidoun, Behboudi-Gandevani Samira

Equivalence TrialСтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

The aim of the study was to investigate the effect of treatment on pregnancy outcomes among women who had fasting plasma glucose (FPG) 5.1-5.6 mmol/l in the first trimester of pregnancy.

METHODS

We performed a secondary-analysis of a randomized community non-inferiority trial of gestational diabetes mellitus (GDM) screening. All pregnant women with FPG values range 5.1-5.6 mmol/l in the first trimester of gestation were included in the present study (n=3297) and classified to either the (i) intervention group who received treatment for GDM along with usual prenatal care (n=1,198), (ii) control group who received usual-prenatal-care (n=2,099). Macrosomia/large for gestational age (LGA) and primary cesarean-section (C-S) were considered as primary-outcomes. A modified-Poisson-regression for binary outcome data with a log link function and robust error variance was used to RR (95%CI) for the associations between GDM status and incidence of pregnancy outcomes.

RESULTS

The mean maternal age and BMI of pregnant women in both study groups were similar. There were no statistically significant differences in the adjusted risks of adverse pregnancy outcomes, including macrosomia, primary C-S, preterm birth, hyperbilirubinemia, preeclampsia, NICU-admission, birth trauma, and LBW both groups.

CONCLUSIONS

It is found that treating women with first-trimester FPG values of 5.1-5.6 mmol/l could not improve adverse pregnancy outcomes including macrosomia, Primary C-S, Preterm birth, hypoglycemia, hypocalcemia, preeclampsia, NICU admission, Birth trauma and LBW. Therefore, extrapolating the FPG cut-off point of the second trimester to the first -which has been proposed by the IADPSG, might therefore not be appropriate.

CLINICAL TRIAL REGISTRATION: https://www.irct.ir/trial/518, identifier IRCT138707081281N1.

Для цитирования: Ramezani Tehrani Fahimeh, Farzadfar Farshad, Hosseinpanah Farhad, Rahmati Maryam, Firouzi Faegheh, Abedini Mehrandokht, Hadaegh Farzad, Valizadeh Majid, Torkestani Farahnaz, Khalili Davood, Solaymani-Dodaran Masoud, Bidhendi-Yarandi Razieh, Bakhshandeh Marzieh, Ostovar Afshin, Dovom Marzieh Rostami, Amiri Mina, Azizi Fereidoun, Behboudi-Gandevani Samira. Does fasting plasma glucose values 5.1-5.6 mmol/l in the first trimester of gestation a matter?. Frontiers in endocrinology. 2023. DOI: 10.3389/fendo.2023.1155007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.